Unknown

Dataset Information

0

Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly.


ABSTRACT: The incidence of early-stage non-small cell lung cancer (NSCLC) among older adults is expected to increase because of demographic trends and computed tomography-based screening; yet, optimal treatment in the elderly remains controversial. Using the Surveillance, Epidemiology, and End Results (SEER)-Medicare cohort spanning 2001-2007, we compared survival outcomes associated with 5 strategies used in contemporary practice: lobectomy, sublobar resection, conventional radiation therapy, stereotactic ablative radiation therapy (SABR), and observation.Treatment strategy and covariates were determined in 10,923 patients aged ? 66 years with stage IA-IB NSCLC. Cox regression, adjusted for patient and tumor factors, compared overall and disease-specific survival for the 5 strategies. In a second exploratory analysis, propensity-score matching was used for comparison of SABR with other options.The median age was 75 years, and 29% had moderate to severe comorbidities. Treatment distribution was lobectomy (59%), sublobar resection (11.7%), conventional radiation (14.8%), observation (12.6%), and SABR (1.1%). In Cox regression analysis with a median follow-up time of 3.2 years, SABR was associated with the lowest risk of death within 6 months of diagnosis (hazard ratio [HR] 0.48; 95% confidence interval [CI] 0.38-0.63; referent is lobectomy). After 6 months, lobectomy was associated with the best overall and disease-specific survival. In the propensity-score matched analysis, survival after SABR was similar to that after lobectomy (HR 0.71; 95% CI 0.45-1.12; referent is SABR). Conventional radiation and observation were associated with poor outcomes in all analyses.In this population-based experience, lobectomy was associated with the best long-term outcomes in fit elderly patients with early-stage NSCLC. Exploratory analysis of SABR early adopters suggests efficacy comparable with that of surgery in select populations. Evaluation of these therapies in randomized trials is urgently needed.

SUBMITTER: Shirvani SM 

PROVIDER: S-EPMC3776428 | biostudies-literature | 2012 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly.

Shirvani Shervin M SM   Jiang Jing J   Chang Joe Y JY   Welsh James W JW   Gomez Daniel R DR   Swisher Stephen S   Buchholz Thomas A TA   Smith Benjamin D BD  

International journal of radiation oncology, biology, physics 20120911 5


<h4>Purpose</h4>The incidence of early-stage non-small cell lung cancer (NSCLC) among older adults is expected to increase because of demographic trends and computed tomography-based screening; yet, optimal treatment in the elderly remains controversial. Using the Surveillance, Epidemiology, and End Results (SEER)-Medicare cohort spanning 2001-2007, we compared survival outcomes associated with 5 strategies used in contemporary practice: lobectomy, sublobar resection, conventional radiation ther  ...[more]

Similar Datasets

| S-EPMC4062652 | biostudies-literature
| S-EPMC2817815 | biostudies-literature
| S-EPMC7879224 | biostudies-literature
| S-EPMC7368734 | biostudies-literature
| S-EPMC5972990 | biostudies-literature
| S-EPMC4401470 | biostudies-literature
| S-EPMC7330760 | biostudies-literature
| S-EPMC3387223 | biostudies-literature
| S-EPMC4493429 | biostudies-literature
| S-EPMC5502824 | biostudies-literature